Recombinant multi-species LIN28A/Lin-28A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LIN28A/Lin-28A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a LIN-28 family RNA-binding protein that acts as a posttranscriptional regulator of genes involved in developmental timing and self-renewal in embryonic stem cells. The encoded protein functions through direct interaction with target mRNAs and by disrupting the maturation of certain miRNAs involved in embryonic development. This protein prevents the terminal processing of the LET7 family of microRNAs which are major regulators of cellular growth and differentiation. Aberrant expression of this gene is associated with cancer progression in multiple tissues. [provided by RefSeq, Sep 2015]
The Alternative Names of target: CSDD1,Gm10299,LIN-28,LIN28,LIN28A,Lin-28,Lin-28A,Lin28,Lin28a,Protein lin-28 homolog A,RGD1566408,Tex17,ZCCHC1,Zinc finger CCHC domain-containing protein 1,lin-28A

Target products collectionGo to LIN28A/Lin-28A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T49593-Ag-1/ GM-Tg-hg-T49593-Ag-2 Human LIN28A/Lin-28A protein Human
GM-Tg-rg-T49593-Ag-1/ GM-Tg-rg-T49593-Ag-2 Rat LIN28A/Lin-28A protein Rat
GM-Tg-mg-T49593-Ag-1/ GM-Tg-mg-T49593-Ag-2 Mouse LIN28A/Lin-28A protein Mouse
GM-Tg-cynog-T49593-Ag-1/ GM-Tg-cynog-T49593-Ag-2 Cynomolgus/Rhesus macaque LIN28A/Lin-28A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T49593-Ag-1/ GM-Tg-felg-T49593-Ag-2 Feline LIN28A/Lin-28A protein Feline
GM-Tg-cang-T49593-Ag-1/ GM-Tg-cang-T49593-Ag-2 Canine LIN28A/Lin-28A protein Canine
GM-Tg-bovg-T49593-Ag-1/ GM-Tg-bovg-T49593-Ag-2 Bovine LIN28A/Lin-28A protein Bovine
GM-Tg-equg-T49593-Ag-1/ GM-Tg-equg-T49593-Ag-2 Equine LIN28A/Lin-28A protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T49593-Ag-1/ GM-Tg-hg-T49593-Ag-2; GM-Tg-rg-T49593-Ag-1/ GM-Tg-rg-T49593-Ag-2;
GM-Tg-mg-T49593-Ag-1/ GM-Tg-mg-T49593-Ag-2; GM-Tg-cynog-T49593-Ag-1/ GM-Tg-cynog-T49593-Ag-2;
GM-Tg-felg-T49593-Ag-1/ GM-Tg-felg-T49593-Ag-2; GM-Tg-cang-T49593-Ag-1/ GM-Tg-cang-T49593-Ag-2;
GM-Tg-bovg-T49593-Ag-1/ GM-Tg-bovg-T49593-Ag-2; GM-Tg-equg-T49593-Ag-1/ GM-Tg-equg-T49593-Ag-2
Products Name LIN28A/Lin-28A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LIN28A/Lin-28A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LIN28A/Lin-28A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.